cyclosporin therapi advanc langerhan cell histiocytosi evid langerhan histiocytosi lch nonmalign disord immun regul cyclosporin mg/kg/d young children advanc multisystem lch patient partial respons month therapi complet resolut organ dysfunct regress major lesion complet respons nontox chemotherapi ie prednison vinblastin toxic cyclosporin mild revers elev serum creatinin blood urea nitrogen result evalu cyclosporin treatment patient advanc lch 